eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-HRMY-Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc HRMY

$36.89-1.08(-2.84%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Harmony Biosciences Holdings Inc
Today
Create an eToro account to buy HRMY stock on a secure, user-friendly, multi-asset trading platform.
Buy Harmony Biosciences Holdings Inc
Buy Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc HRMY
Buy HRMY
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Moderate Buy
Price Target
59.50
Based on analysts who covered HRMY

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Harmony Biosciences Holdings Inc News

About Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc provides unique solutions to medicine and healthcare. Its primary operations are within the US.

Harmony Biosciences Holdings Inc is a notable player in the healthcare sector, producing pivotal services to manage and combat neurological conditions. Harmony Biosciences Holdings Inc focuses on developing and delivering treatments for rare neurological diseases. The company stands out due to its unwavering commitment to advancing patient care and expanding treatment options in the neuroscience therapeutic area.

Stay up to date on the share price of HRMY by adding it to your eToro watchlist.
VIEW MORE   

HRMY Stock Price Chart

‎2.05‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Harmony Biosciences Holdings Inc share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Harmony Biosciences Holdings Inc share price today is $36.89, reflecting a ‎-2.84‎% change over the last 24 hours and ‎-0.78‎% over the past week. The current market capitalization of HRMY is $2.12B with an average volume in the last three months of 584848.81. The stock has a P/E ratio of 11.89 and a dividend yield of 0%. With the stock’s beta sitting at 0.79
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$2.12B
Day’s Range
i
Shows the high and low prices of the day.
$36.67 - $37.74
52W Range
i
Shows the high and low prices of the last year.
$26.06 - $41.52
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
584848.81
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
11.89
Revenue
i
The total income generated by this company’s goods and services last year.
$772.53M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
$0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$36.89
EPS
i
A company’s total earnings divided by the number of shares it has issued.
$3.1
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.79
What Is Harmony Biosciences Holdings Inc?
Harmony Biosciences Holdings Inc provides unique solutions to medicine and healthcare. Its primary operations are within the US.

Harmony Biosciences Holdings Inc is a notable player in the healthcare sector, producing pivotal services to manage and combat neurological conditions. Harmony Biosciences Holdings Inc focuses on developing and delivering treatments for rare neurological diseases. The company stands out due to its unwavering commitment to advancing patient care and expanding treatment options in the neuroscience therapeutic area.

Stay up to date on the share price of HRMY by adding it to your eToro watchlist.
CEO
Jeffrey M. Dayno, MD
Employees
268
Founded
2017
HQ
Plymouth Meeting, Pennsylvania, US
Med Tech
NASDAQ
Buy HRMY

How can I buy Harmony Biosciences Holdings Inc stocks?

To purchase Harmony Biosciences Holdings Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Harmony Biosciences Holdings Inc (HRMY) page and place an order to buy Harmony Biosciences Holdings Inc.
Buy HRMY
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Harmony Biosciences Holdings Inc
Invest in Harmony Biosciences Holdings Inc
Today
Create an eToro account to buy HRMY stock on a secure, user-friendly, multi-asset trading platform.
Buy HRMY

FAQ

The current price of HRMY is $36.89.
The average price target for Harmony Biosciences Holdings Inc is $59.50. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Harmony Biosciences Holdings Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Harmony Biosciences Holdings Inc is $2.12B
Based on 3 analysts offering recommendations for HRMY in the last 3 months, the overall consensus is Moderate Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top